STOCKHOLM, Sweden, Sept. 26, 2005 (PRIMEZONE) -- Elekta has named James P. Hoey as president and CEO of IMPAC Medical Systems, Inc., part of the Elekta Group and a leading provider of information technology solutions for oncology care. Mr. Hoey is one of three original founders of IMPAC, and has been integral in operation management of the company since 1990, most recently serving as IMPAC chief operating officer. Mr. Hoey was instrumental in developing IMPAC into the leading supplier of image and data management software for cancer therapy.
Joseph K. Jachinowski, former president and CEO of IMPAC, has been appointed as the executive vice president of product creation for the entire Elekta Group. Mr. Jachinowski's responsibilities include product development and product management of all Elekta product lines, including Elekta Synergy(R), Leksell Gamma Knife(R) and Elekta Neuromag(R) as well as IMPAC's product portfolio. Mr. Jachinowski, one of IMPAC's original founders, has extensive experience in product creation and eagerly accepted the challenge of the new position.
The new organization will facilitate the Elekta Group's efforts to realize the inherent synergies between the two companies. "IMPAC's continued mission is to provide the best oncology information management system for our customers," stated Mr. Hoey.
Mr. Jachinowski added, ``The development efforts with Elekta will enable us to take a broader look at oncology needs and devote corporate-wide resources and expertise appropriately. With our worldwide installed base of EMRs integrated with linacs from multiple manufacturers, we can leverage our experience to provide a unique perspective on the management of oncology care."
For further information, please contact:
International: Peter Ejemyr Group VP Corporate Communications, Elekta AB Tel: +46 733 611 000 e-mail: peter.ejemyr@elekta.com US: Lars Jonsteg VP Investor Relations North America, Elekta, USA Tel: +46 708 78 37 35 e-mail: lars.jonsteg@elekta.com
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife(R) for non-invasive treatment of brain surgery and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1700 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.
This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=134174&fn=wkr0001.pdf
PDF version